GeneNews Ltd (TSE:GEN) shares fell 10.7% during trading on Wednesday . The company traded as low as C$0.13 and last traded at C$0.13. 502,073 shares were traded during mid-day trading, a decline of 75% from the average session volume of 1,973,159 shares. The stock had previously closed at C$0.14.
The firm has a market capitalization of $23.80 million and a P/E ratio of -3.68.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by BBNS and is owned by of BBNS. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://baseballnewssource.com/2019/04/17/genenews-gen-trading-down-10-7/3359432.html.
About GeneNews (TSE:GEN)
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Read More: What is the Coverage Ratio?
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.